Hartz SM, Pato CN, Medeiros H, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014;71(3):248-54. doi:10.1001/jamapsychiatry.2013.3726
Leussis MP, Berry-Scott EM, Saito M, et al. The ANK3 bipolar disorder gene regulates psychiatric-related behaviors that are modulated by lithium and stress. Biol Psychiatry. 2013;73(7):683-90. doi:10.1016/j.biopsych.2012.10.016
Hyman SE. Revolution stalled. Sci Transl Med. 2012;4(155):155cm11. doi:10.1126/scitranslmed.3003142
Rueckert EH, Barker D, Ruderfer D, et al. Cis-acting regulation of brain-specific ANK3 gene expression by a genetic variant associated with bipolar disorder. Mol Psychiatry. 2013;18(8):922-9. doi:10.1038/mp.2012.104
Bergen SE, O’Dushlaine CT, Ripke S, et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry. 2012;17(9):880-6. doi:10.1038/mp.2012.73
Scolnick EM. Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations. Biol Psychiatry. 2006;59(11):1039-45. doi:10.1016/j.biopsych.2006.02.022
Fan J, Ionita-Laza I, McQueen MB, et al. Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(1):29-37. doi:10.1002/ajmg.b.30942
Green EK, Rees E, Walters JTR, et al. Copy number variation in bipolar disorder. Mol Psychiatry. 2016;21(1):89-93. doi:10.1038/mp.2014.174
Bavamian S, Mellios N, Lalonde J, et al. Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. Mol Psychiatry. 2015;20(5):573-84. doi:10.1038/mp.2014.176
Madison JM, Zhou F, Nigam A, et al. Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities. Mol Psychiatry. 2015;20(6):703-17. doi:10.1038/mp.2015.7